New Orleans, Louisiana, played host to the 59th annual Pittsburgh conference and exhibition (Pittcon), which was held March 1–7 at the Ernest N. Morial Convention Center. Although Pittcon took place against a backdrop of escalating fears of a US recession, one would have never known it. Companies were upbeat about future business prospects and the […]
Arthur Holden, Illumina Senior Vice President of Corporate and Market Development, resigned from the company in fall 2007. Rosetta Biosoftware’s Syllego System achieved Affymetrix GeneChip-compatibility status. Eppendorf Biochip Systems GmbH certified Girus Life Sciences as a service provider. Oxford Gene Technology granted a license to Phalanx Biotech to fabricate and sell arrays in the US. […]
Eppendorf AG introduced the TF Chip Stem Cell kit. Eppendorf AG and the Joint Research Center of the EU validated the firm’s DualChip GMO microarray kit. BioDiscovery released NEXUS CGH 2 software. Tecan AG introduced the QuadChamber for fully automated processing of four different microarrays simultaneously on one slide, which is validated for use with […]
Affymetrix received a four-year, $10.2 million grant from the National Human Genome Research Institute for the ENCODE (ENCylopedia Of DNA Elements) project. Laboratory Corporation of America will use Affymetrix’s whole genome microarrays for a new molecular cytogenetic service for the US.
The life science instrumentation market grew 8.7% to $9.2 billion in 2007. The market consists of DNA and peptide sequencers, DNA and peptide synthesizers, nucleic acid amplification or polymerase chain reaction (PCR) systems, gel electrophoresis equipment, molecular biology purification kits, microarray-based products, biosensors, bioinformatics and cheminformatics, cell analysis technologies and in vivo animal imaging. The […]
Santa Clara CA 12/18/07—Affymetrix has agreed to acquire USB, a manufacturer of molecular biology and biochemical reagents, for approximately $75 million in cash. Based in Cleveland, Ohio, USB offers three major product lines: molecular biology enzymes and kits, biochemical reagents and products for membrane protein research. “The integration of USB’s biochemical reagents with Affymetrix’s current […]
Jena and Itzehoe, Germany 11/6/07—Analytik Jena AG has announced that it acquired a 70% share in eBiochip Systems GmbH for an undisclosed amount in October. EBiochip produces electronic biochips for research and diagnostics. “We believe this technology to be an interesting and competitive alternative to other systems available on the market in the growth sector […]
Affymetrix and Partners Healthcare extended their translational research collaboration (see IBO 12/15/06) with a contract array manufacturing supply agreement. Affymetrix and IPSOGEN will collaborate to develop and market in vitro diagnostic tests. Empire Genomics, a molecular karyotyping platform technology company, licensed a number of Affymetrix’s patents covering the manufacturing, use and sales of microarrays and […]
In July, Illumina introduced the Infinium HumanHap550-Duo BeadChip, a two-chip format for greater throughput and lower cost per sample, priced at $290–$370 per sample, depending on volume. Illumina launched the Infinium HumanLinkage-12 Genotyping BeadChip, available for $90 per sample. Roche NimbleGen introduced four-plex eukaryotic gene expression microarrays and services in September. In September, Affymetrix officially […]
Tokyo, Japan 9/25/07—Japan’s Nikkei News reports that Toshiba, Canon, Toray Industries, Yokogawa Electric and seven other Japanese firms, supported by the Kazusa DNA Research Institute, will form a consortium to develop microarrays for applications in diagnostic medicine, food and environmental analysis. According to Nikkei, the Japanese microarray market will total ¥100 billion ($869.2 million) by […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
